Alzinova AB
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
ALZ | ST
Overview
Corporate Details
- ISIN(s):
- SE0007413455
- LEI:
- 549300K3IMVT20EK2S13
- Country:
- Sweden
- Address:
- Pepparedsleden 1, 431 83 MÖLNDAL
- Website:
- https://www.alzinova.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Alzinova AB is a clinical-stage biopharmaceutical company specializing in the development of disease-modifying treatments for Alzheimer's disease. The company's research is centered on its proprietary AβCC Peptide™ technology, which enables the development of immunotherapies that specifically target neurotoxic amyloid-beta oligomers, a central cause of the disease. Alzinova's pipeline includes both active immunotherapies (vaccines) and passive immunotherapies (antibodies). Its lead candidate, ALZ-101, is a therapeutic vaccine in clinical development designed to be a highly specific treatment to prevent or slow the progression of Alzheimer's disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Alzinova AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Alzinova AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-03 | Tord Evert Sigfried Labuda | Other | Other | 1,000,000 | 260,000.00 SEK |
| 2025-04-03 | Tord Evert Sigfried Labuda | Other | Buy | 10,000 | 18,800.00 SEK |
| 2025-04-02 | Tord Evert Sigfried Labuda | Other | Buy | 20,000 | 40,000.00 SEK |
| 2024-12-16 | Erik Kullgren | Other | Buy | 10,000 | 34,400.00 SEK |
